High stored iron levels are associated with excess risk of myocardial infarction in eastern finnish men

Circulation

Volumn 86, Issue 3, 1992, Pages 803-811

  Salonen, Jukka T ^a   Nyyssönen, Kristiina ^a   Korpela, Heikki ^a   Tuomilehto, Jaakko ^b   Seppänen, Ritva ^c   Salonen, Riitta ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

Coronary heart disease; Ferritin; Hemoglobin; Iron; Myocardial infarction; Population studies

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; DIETARY INTAKE; FERRITIN BLOOD LEVEL; FINLAND; HEART INFARCTION; HUMAN; IRON STORAGE; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGING; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITIN; FINLAND; HEMOGLOBINS; HUMAN; IRON; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0026800818     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.86.3.803     Document Type: Article

References (53)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-923
2. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 1992;339:883-887
3. McCord JM: Is iron sufficiency a risk factor in ischemic heart disease? Circulation 1991;83:1112-1114
4. Cross CE, Halliwell B, Borish ET, Pryor WA, Saul RL, McCord JM, Harman D: Oxygen radicals and human disease. Ann Intern Med 1987;107:526-545
5. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 2. Oxford, Clarendon Press, 1989
6. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview, in Packer L, Glazer AN (eds): Methods in Enzymology, vol 186. San Diego, Academic Press, 1990, pp 1-85
7. Sullivan JL: The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-1188
8. Williams RE, Zweier JL, Flaherty JT: Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 1991;83:1006-1014
9. Salonen JT, Salonen R, Seppänen K, Kantola M, Suntioinen S, Korpela H: Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br Med J 1991;302: 756-760
10. Salonen JT, Salonen R, Korpela H, Suntioinen S, Tuomilehto J: Serum copper and the risk of acute myocardial infarction: A prospective population study in men in eastern Finland. Am J Epidemiol 1991;134:268-276
11. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P: Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982;2:175-179
12. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-1294
13. Salonen JT: Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk factor Study. Ann Clin Res 1988;20:46-50
14. Keys A: Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge/London, Harvard University Press, 1980
15. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. Geneva, World Health Organization, 1982, pp 162-165
16. Salonen JT, Lakka T: Assessment of physical activity in population studies: Validity and consistency of the methods in the Kuopio Ischaemic Heart Disease Risk Factor Study. Scand J Sports Sci 1987;9:89-95
17. Ihanainen M, Salonen R, Seppänen R, Salonen JT: Nutrition data collection in the Kuopio Ischaemic Heart Disease Risk Factor Study: Nutrient intake of middle-aged Eastern Finnish men. Nutr Res 1989;9:597-604
18. Fairbanks VF: Hemoglobin, hemoglobin derivatives, and myoglobin, in Tietz N (ed): Fundamentals of Clinical Chemistry. Philadelphia/London/Toronto, WB Saunders Co, 1976, pp 401-454
19. 3 subfractions and the risk of acute myocardial infarction: A prospective population study in Eastern Finnish men. Circulation 1991;84:129-139
20. Knuts L-R, Rastas M, Haapala P, Seppänen R, Karvetti R-L, Aro A: Nutrica: A computer program for calculation of food and nutrient intake, in Third Eurofoods Meeting, Warsaw, May 24-27, 1987 (programme and abstracts)
21. Simpura J: Scandinavian Drinking Survey: Construction of Indices of Alcohol Intake. SIFA mimeograph no 46, Oslo, 1981
22. WHO Monica Project: WHO Monica Project: Assessing CHD mortality and morbidity. Int J Epidemiol 1989;18:S38-S45
23. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpäa J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T: Acute myocardial infarction (AMI) in Finland: Baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J 1992;13: 577-587
24. Cox DR: Regression models and life-tables. J R Stat Soc 1972;34: 187-201
25. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI: BMDP Statistical Software Manual. Berkeley, University of California Press, 1988
26. Samokyszyn VM, Reif DW, Miller DM, Aust SD: Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation. Free Radic Res Commun 1991;12-13:153-159
27. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM: Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991;11: 1700-1711
28. Wilkins GM, Leake DS: Free radicals and low-density lipoprotein oxidation by macrophages. Biochem Soc Trans 1990;18:1170-1171
29. Kuzuya M, Naito M, Yamada K, Funaki C, Hayashi T, Asai K, Kuzuya F: Involvement of intracellular iron in the toxicity oxidized low density lipoprotein to cultured endothelial cells. Biochem Int 1990;22:567-573
30. Itabe H, Kobayashi T, Inoue K: Generation of toxic phospholipid(s) during oxyhemoglobin-induced peroxidation of phosphatidylcholines. Biochim Biophys Acta 1988;961:13-21
31. Carlin G, Djursater R: Xanthine oxidase induced depolymerization of hyaluronic acid in the presence of ferritin. FEBS Lett 1984;177:27-30
32. Cozzi A, Santambrogio P, Levi S, Arosio P: Iron detoxifying activity of ferritin: Effects of H and L apoferritins on lipid peroxidation in vitro. FEBS Lett 1990;277:119-122
33. Aruoma OI, Bomford A, Polson RJ, Halliwell B: Nontransferrin-bound iron in plasma from hemochromatosis patients: Effect of phlebotomy therapy. Blood 1988;72:1416-1419
34. van der Kraaij A, Mostert LJ, van Eijk HG, Koster JF: Iron load increases the susceptibility of rat hearts to oxygen reperfusion damage: Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation 1988;78:442-449
35. Korpela H: Increased myocardial and hepatic iron concentration in pigs with microangiopathy (Mulberry heart disease) as a risk factor of oxidative damage. Ann Nutr Metab 1990;34:193-197
36. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B: Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J (in press)
37. Murray MJ, Murray AB, Murray NJ: Nutritional iron and copper deficiency may protect against the atherogenesis of high-fat diets. (abstract) Arterioscler Thromb 1991;11:1479a
38. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL: Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci Mol Med 1974;47:215-222
39. Sullivan JL: Stored iron as a risk factor for ischemic heart disease, in Lauffer RB (ed): Iron and Human Disease. Boca Raton, Fla, CRC Press, 1992
40. Wolfe L, Olivieri N, Sallan D, Colan S, Rose V, Propper R, Freedman MH, Nathan DG: Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 1985;312:1600-1603
41. Lauffer RB: Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 1991;35:96-102
42. Gordon T, Kannel WB, Hjortland MC, McNamara PM: Menopause and coronary heart disease: The Framingham Study. Ann Intern Med 1978;89:157-161
43. Böttiger LE, Carlson LA: Risk factors for ischaemic vascular death for men in the Stockholm Prospective Study. Atherosclerosis 1980; 36:389-408
44. Cullen KJ, Stenhouse NS, Waerne KL: Raised haemoglobin and risk of cardiovascular disease. Lancet 1981;4:1288-1289
45. Knottnerus JA, Swaen GMH, Slangen JJM, Volovics A, Durinck J: Haematologic parameters as risk factors for cardiac infarction in an occupational health care setting. J Clin Epidemiol 1988;41:67-74
46. Willett W: Nutritional Epidemiology. New York, Oxford University Press, 1990
47. Cook JD, Lipschitz DA, Miles LE, Finch CA: Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27: 681-687
48. Kaltwasser JP, Werner E: Diagnosis and clinical evaluation of iron overload. Baillieres Clin Haematol 1989;2:363-385
49. Lauffer RB: Exercise as prevention: Do the health benefits derive in part from lower iron levels? Med Hypotheses 1991;35:103-107
50. Zidek W, Tenschert W, Karoff C, Vetter H: Treatment of resistant hypertension by phlebotomy. Klin Wochenschr 1985;63:762-764
51. Cook JD, Finch CA, Smith NJ: Evaluation of the iron status of a population. Blood 1976;48:449-455
52. Jonsson JJ, Johannesson GM, Sigfusson N, Magnusson B, Thjodleifsson B, Magnusson S: Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol 1991;44:1289-1297
53. Munro HN, Linder MC: Ferritin: Structure, biosynthesis, and role in iron metabolism. Physiol Rev 1978;58:317-396